ISSN: 2332-0877

Zeitschrift für Infektionskrankheiten und Therapie

Offener Zugang

Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Abstrakt

Estimation of Anti-Tubercular Drug Resistance in Relapse TB Patients in Rims Hospital, Srikakulam

Harikrishna Allu, Sowmyasree Mudakala, Madhavi Singupuram and Udaya Sri Kaviti

Relapse TB means the patient had a TB he was previously been treated for TB. Most of such patients had Multi-Drug resistance for first line TB treatment. Method and Materials: These studies were conducted based on observational study in this study we utilized quantitative method to find an effected population. Result: we gathered total 150 population in the period of six months in that 63 individuals were sent for CBNAT test (Rifampicin Resistant test) out of that 40 samples were got a positive results to Rifampicin Resistant, in that male 36 (57.1%) were higher than females 4(6.3%) and adults 31(49.2%) were more than the other age groups, based on the location Srikakulam zone were higher than the other zones. Conclusion: Relapse TB and Multidrug resistant caused due to failure of TB treatment, infected with drug resistant mycobacteria.